{
  "main_header": {
    "sid": 197397,
    "name": "Syngene Intl.",
    "stock_name": "Syngene Intl.",
    "full_name": "Syngene International Ltd",
    "name_url": "stocks-analysis/syngene-intl",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "646.35",
    "chg": 6,
    "chgp": "0.94%",
    "dir": 1,
    "prev_price": "640.35",
    "mcapval": "26,088.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 539268,
    "symbol": "SYNGENE",
    "ind_name": "Healthcare Services",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE398R01022",
    "curr_date": "Dec 12",
    "curr_time": "",
    "bse_nse_vol": "7.83 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 12, 2025",
    "traded_date_str": "2025 12 12",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/syngene-intl-197397-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Syngene International Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syngene-international-technical-momentum-shifts-amid-bearish-signals-3754605",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SyngeneInternat_technicaldot_3754605.png",
        "date": "2025-12-10 08:01:13",
        "description": "Syngene International’s recent market activity reflects a nuanced shift in technical momentum, with a blend of bearish and mildly bullish indicators shaping investor sentiment. The stock’s price movement and key technical parameters reveal a complex landscape for this healthcare services company as it navigates current market conditions."
      },
      {
        "title": "Syngene International’s Market Assessment Reflects Mixed Signals Amidst Financial and Technical Shifts",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syngene-international-downgraded-to-sell-amid-mixed-technicals-and-weak-financials-3752759",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SyngeneInternat_mojoScore_3752759.png",
        "date": "2025-12-09 08:10:05",
        "description": "Syngene International, a key player in the Healthcare Services sector, has experienced a revision in its market evaluation driven by a combination of technical indicators and financial performance metrics. This nuanced shift reflects a complex interplay between recent price trends, valuation considerations, and underlying business fundamentals."
      },
      {
        "title": "Syngene International Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syngene-international-technical-momentum-shifts-amid-bearish-sentiment-3752645",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SyngeneInternat_technicaldot_3752645.png",
        "date": "2025-12-09 08:03:03",
        "description": "Syngene International, a key player in the Healthcare Services sector, is exhibiting a nuanced shift in its technical momentum as recent market data reveals a transition from a bearish to a mildly bearish trend. This development comes amid a complex interplay of technical indicators, including MACD, RSI, moving averages, and Bollinger Bands, which collectively paint a mixed picture for investors analysing the stock’s near-term trajectory."
      },
      {
        "title": "Syngene International Technical Momentum Shifts Amid Bearish Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syngene-international-faces-bearish-momentum-amid-technical-downturn-3750272",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SyngeneInternat_technicaldot_3750272.png",
        "date": "2025-12-08 08:00:50",
        "description": "Syngene International, a key player in the Healthcare Services sector, is exhibiting a notable shift in its technical momentum as recent evaluation adjustments reflect a transition towards bearish trends. The stock’s price action, combined with mixed signals from key technical indicators such as MACD, RSI, and moving averages, suggests a complex market assessment for investors navigating this healthcare services stock."
      },
      {
        "title": "Is Syngene Intl. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-syngene-intl-technically-bullish-or-bearish-3747540",
        "imagepath": "",
        "date": "2025-12-05 08:17:41",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Technical Trend Overview</strong></p>\n<p>As of 04 Dec 2025, Syngene International's technical trend has transitioned from a clear bearish stance to a mildly bearish one. This subtle shift suggests that while the stock is not in a strong downtrend, it has yet to establish a definitive bullish momentum. The change indicates a potential stabilisation phase, but caution remains warranted given the mixed signals from key technical indicators.</p>\n<p><strong>Key Technical Indicators: Weekly and Monthly Perspectives</strong></p>\n<p>Examining the Moving Average Convergence Divergence (MACD), the weekly chart shows a mildly bullish signal, hinting at some upward momentum in the short term. However, the monthly MACD remains bearish, reflecting longer-term caution. This divergence between weekly and mo..."
      },
      {
        "title": "Syngene International Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syngene-international-technical-momentum-shifts-amid-bearish-outlook-3747479",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SyngeneInternat_technicaldot_3747479.png",
        "date": "2025-12-05 08:01:18",
        "description": "Syngene International’s stock has exhibited a nuanced shift in technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Recent evaluation adjustments highlight a transition from a predominantly bearish stance to a more mildly bearish outlook, with key indicators such as MACD and moving averages signalling subtle changes in price dynamics."
      },
      {
        "title": "Syngene International Faces Shift in Market Assessment Amidst Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syngene-international-downgraded-to-strong-sell-amid-weak-financials-and-bearish-technicals-3742904",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SyngeneInternat_mojoScore_3742904.png",
        "date": "2025-12-03 08:05:52",
        "description": "Syngene International, a key player in the healthcare services sector, has experienced a notable shift in its market evaluation, reflecting a complex interplay of financial performance, valuation metrics, and technical indicators. This article analyses the recent changes in the company’s assessment across four critical parameters: quality, valuation, financial trend, and technicals."
      },
      {
        "title": "Syngene International Faces Bearish Momentum Amid Technical Shifts",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syngene-international-faces-bearish-momentum-amid-technical-downturn-3742736",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SyngeneInternat_technicaldot_3742736.png",
        "date": "2025-12-03 08:01:48",
        "description": "Syngene International, a key player in the Healthcare Services sector, is currently exhibiting a shift in its technical momentum, with several indicators signalling a bearish trend. The stock’s recent price movements and technical parameters suggest a cautious outlook as it navigates a challenging market environment."
      },
      {
        "title": "How has been the historical performance of Syngene Intl.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-syngene-intl-3742196",
        "imagepath": "",
        "date": "2025-12-02 22:51:16",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profit Growth</strong></p>\n<p>Syngene International’s net sales have shown consistent expansion, rising from ₹1,825.60 crores in March 2019 to ₹3,642.40 crores by March 2025. This represents a compound growth trend reflecting the company’s ability to scale its operations effectively. Correspondingly, total operating income mirrored this upward movement, with no other operating income reported during this period, indicating a primary reliance on core business activities.</p>\n<p>Operating profit before depreciation and interest (PBDIT) excluding other income increased from ₹536.80 crores in 2019 to ₹1,041.80 crores in 2025, underscoring improved operational efficiency. Including other income, operating profit rose to ₹1,113.60 crores in the latest fiscal year. Profit before tax als..."
      }
    ],
    "total": 246,
    "sid": "197397",
    "stock_news_url": "https://www.marketsmojo.com/news/syngene-international-197397"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "11-Dec-2025",
      "details": "Intimation of Webinar on Clinical Trials Market",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "08-Dec-2025",
      "details": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find the details of the meeting to be held with the Analyst/Institutional Investor.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "08-Dec-2025",
      "details": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find the details of the meeting to be held with the Analyst/Institutional Investor.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Syngene International Ltd has declared <strong>12%</strong> dividend, ex-date: 27 Jun 25",
          "dt": "2025-06-27",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Syngene International Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 11 Jun 19",
          "dt": "2019-06-11",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Syngene International Technical Momentum Shifts Amid Mixed Market Signals

2025-12-10 08:01:13

Syngene International’s recent market activity reflects a nuanced shift in technical momentum, with a blend of bearish and mildly bullish indicators shaping investor sentiment. The stock’s price movement and key technical parameters reveal a complex landscape for this healthcare services company as it navigates current market conditions.

Read More

Syngene International’s Market Assessment Reflects Mixed Signals Amidst Financial and Technical Shifts

2025-12-09 08:10:05

Syngene International, a key player in the Healthcare Services sector, has experienced a revision in its market evaluation driven by a combination of technical indicators and financial performance metrics. This nuanced shift reflects a complex interplay between recent price trends, valuation considerations, and underlying business fundamentals.

Read More

Syngene International Technical Momentum Shifts Amid Mixed Market Signals

2025-12-09 08:03:03

Syngene International, a key player in the Healthcare Services sector, is exhibiting a nuanced shift in its technical momentum as recent market data reveals a transition from a bearish to a mildly bearish trend. This development comes amid a complex interplay of technical indicators, including MACD, RSI, moving averages, and Bollinger Bands, which collectively paint a mixed picture for investors analysing the stock’s near-term trajectory.

Read More

Syngene International Technical Momentum Shifts Amid Bearish Signals

2025-12-08 08:00:50

Syngene International, a key player in the Healthcare Services sector, is exhibiting a notable shift in its technical momentum as recent evaluation adjustments reflect a transition towards bearish trends. The stock’s price action, combined with mixed signals from key technical indicators such as MACD, RSI, and moving averages, suggests a complex market assessment for investors navigating this healthcare services stock.

Read More

Is Syngene Intl. technically bullish or bearish?

2025-12-05 08:17:41

Technical Trend Overview

As of 04 Dec 2025, Syngene International's technical trend has transitioned from a clear bearish stance to a mildly bearish one. This subtle shift suggests that while the stock is not in a strong downtrend, it has yet to establish a definitive bullish momentum. The change indicates a potential stabilisation phase, but caution remains warranted given the mixed signals from key technical indicators.

Key Technical Indicators: Weekly and Monthly Perspectives

Examining the Moving Average Convergence Divergence (MACD), the weekly chart shows a mildly bullish signal, hinting at some upward momentum in the short term. However, the monthly MACD remains bearish, reflecting longer-term caution. This divergence between weekly and mo...

Read More

Syngene International Technical Momentum Shifts Amid Mixed Market Signals

2025-12-05 08:01:18

Syngene International’s stock has exhibited a nuanced shift in technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Recent evaluation adjustments highlight a transition from a predominantly bearish stance to a more mildly bearish outlook, with key indicators such as MACD and moving averages signalling subtle changes in price dynamics.

Read More

Syngene International Faces Shift in Market Assessment Amidst Mixed Financial and Technical Signals

2025-12-03 08:05:52

Syngene International, a key player in the healthcare services sector, has experienced a notable shift in its market evaluation, reflecting a complex interplay of financial performance, valuation metrics, and technical indicators. This article analyses the recent changes in the company’s assessment across four critical parameters: quality, valuation, financial trend, and technicals.

Read More

Syngene International Faces Bearish Momentum Amid Technical Shifts

2025-12-03 08:01:48

Syngene International, a key player in the Healthcare Services sector, is currently exhibiting a shift in its technical momentum, with several indicators signalling a bearish trend. The stock’s recent price movements and technical parameters suggest a cautious outlook as it navigates a challenging market environment.

Read More

How has been the historical performance of Syngene Intl.?

2025-12-02 22:51:16

Revenue and Profit Growth

Syngene International’s net sales have shown consistent expansion, rising from ₹1,825.60 crores in March 2019 to ₹3,642.40 crores by March 2025. This represents a compound growth trend reflecting the company’s ability to scale its operations effectively. Correspondingly, total operating income mirrored this upward movement, with no other operating income reported during this period, indicating a primary reliance on core business activities.

Operating profit before depreciation and interest (PBDIT) excluding other income increased from ₹536.80 crores in 2019 to ₹1,041.80 crores in 2025, underscoring improved operational efficiency. Including other income, operating profit rose to ₹1,113.60 crores in the latest fiscal year. Profit before tax als...

Read More

View All News